Dependence on PI3K/Akt signaling for malignant rhabdoid tumor cell survival

Cancer Chemotherapy and Pharmacology

Volumn 63, Issue 5, 2009, Pages 783-791

  Foster, Kristen ^a   Wang, Yong ^a   Zhou, Daohong ^a   Wright, Cynthia ^a  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

Akt; Malignant rhabdoid tumor; NVP AEW541; Oncogene addiction; PI3K; SWI SNF

Indexed keywords

2 MORPHOLINO 8 PHENYLCHROMONE; GROWTH FACTOR RECEPTOR; NVP AEW 541; PHOSPHATIDYLINOSITOL 3 KINASE; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; PROTEIN KINASE B; RAPAMYCIN; SOMATOMEDIN C RECEPTOR;

ARTICLE; CANCER CELL; CANCER GROWTH; CELL SURVIVAL; CONTROLLED STUDY; DRUG SENSITIVITY; ENZYME ACTIVATION; ENZYME INHIBITION; ENZYME PHOSPHORYLATION; HUMAN; HUMAN CELL; IN VITRO STUDY; MALIGNANT NEOPLASTIC DISEASE; ONCOGENE RAS; PRIORITY JOURNAL; RHABDOID TUMOR; SIGNAL TRANSDUCTION;

1-PHOSPHATIDYLINOSITOL 3-KINASE; BLOTTING, WESTERN; CELL PROLIFERATION; CELL SURVIVAL; HELA CELLS; HUMANS; IMMUNOPRECIPITATION; PHOSPHORYLATION; PROTO-ONCOGENE PROTEINS C-AKT; PYRIMIDINES; PYRROLES; RAS PROTEINS; RECEPTOR, IGF TYPE 1; RHABDOID TUMOR; SIGNAL TRANSDUCTION; TUMOR CELLS, CULTURED;

EID: 61449174877     PISSN: 03445704     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00280-008-0796-5     Document Type: Article

References (61)

1. JA Biegel LB Rorke RJ Packer BS Emanuel 1990 Monosomey 22 in rhabdoid or atypical tumors of the brain J Neurosurg 73 710 714
2. JA Biegel CS Allen K Kawasaki N Shimizi ML Budarf CJ Bell 1996 Narrowing the critical region for a rhabdoid tumor locus in 22q11 Genes Chromosomes Cancer 16 94 105
3. PC Burger IT Yu T Tihan HS Friedman DR Strother JL Kepner PK Duffner LE Kun EJ Perlman 1998 Atypical teratoid/rhabdoid tumor of the central nervous system: a highly malignant tumor of infancy and childhood frequently mistaken for medulloblastoma: a pediatric oncology group study Am J Surg Pathol 22 1083 1092
4. I Versteege N Sévenet J Lange M Rousseau-Merck P Ambros R Handgretinger A Aurias O Delattre 1998 Truncating mutations of hSNF5/INI1 in aggressive paediatric cancer Nature 394 203 206
5. JA Biegel J Zhou LB Rorke C Stenstrom LM Wainwright B Fogelgren 1999 Germ-line and acquired mutations of INI1 in atypical teratoid and rhabdoid tumors Cancer Res 59 74 79
6. MF DeCristofaro BL Betz W Wang BE Weissman 1999 Alteration of hSNF5/INI1/BAF47 detected in rhabdoid cell lines and primary rhabdomyosarcomas but not Wilms' tumor Oncogene 18 7559 7565
7. CJ Guidi AT Sands BP Zambrowica TK Turner DA Demers W Webster TW Smith AN Imbalzano SN Jones 2001 Disruption of INI1 leads to peri-implantation lethality and tumorigenesis in mice Mol Cell Biol 21 3598 3603
8. A Klochendler-Yeivin L Fiette J Barra C Muchardt C Babinet M Yaniv 2000 The murine SNF5/INI1 chromatin remodeling factor is essential for embryonic development and tumor suppression EMBO Rep 1 500 506
9. CWM Roberts SA Galusha ME McMenamin CDM Fletcher SH Orkin 2000 Haploinsufficiency of Snf5 (integrase interactor 1) predisposes to malignant rhabdoid tumors in mice Proc Natl Acad Sci USA 97 13796 13800
10. BL Betz MW Strobeck DN Reisman ES Knudsen BE Weissman 2002 Re-expression of hSNF5/INI1/BAF47 in pediatric tumor cells leads to G1 arrest associated with induction of p16ink4a and activation of RB Oncogene 21 5193 5203
11. I Versteege S Medjkane D Rouillard O Delattre 2002 A key role of the hSNF5/INI1 tumour suppressor in the control of the G1-S transition of the cell cycle Oncogene 21 6403 6412
12. Z-K Zhang KP Davies J Allen L Ahu RG Pestell D Zagzag G Kalpana 2002 Cell cycle arrest and repression of cyclin D1 transcription by INI1/hSNF5 Mol Cell Biol 22 5975 5988
13. BS Reincke GB Rosson BW Oswald CF Wright 2003 INI1 expression induces cell cycle arrest and markers of senescence in malignant rhabdoid tumor cells J Cell Physiol 194 303 313
14. JL Dunaief BE Strober S Guha PA Khavari K Alin J Luban M Begemann GR Crabtree SP Goff 1994 The retinoblastoma protein and BRG1 form a complex and cooperate to induce cell cycle arrest Cell 79 119 130
15. D Trouche C LeChalony C Muchardt M Yaniv T Kouzarides 1997 RB and hbrm cooperate to repress the activation functions of E2F1 Proc Natl Acad Sci USA 94 11268 11273
16. I Oruetxebarria F Venturini T Kekarainen A Houweling LM Zuijderduijn A Mohd-Sarip RG Vries RC Hoeben CP Verrijzer 2004 P16INK4a is required for hSNG5 chromatin remodeler-induced cellular senescence in malignant rhabdoid tumor cells J Biol Chem 279 3807 3816
17. S Kadam BM Emerson 2003 Transcriptional specificity of human SWI/SNF BRG1 and BRM chromatin remodeling complexes Mol Cell 11 377 389
18. CIP1/WAF1/SDI Mol Cell Biol 24 1188 1199
19. D Lee JW Kim T Seo SG Hwang EJ Choi J Choe 2002 SWI/SNF complex interacts with tumor suppressor p53 and is necessary for the activation of p53-mediated transcription J Biol Chem 277 22330 22337
20. FC Holstege EG Jennings JJ Wyrick TI Lee CJ Hengartner MR Green TR Golub ES Lander RA Young 1998 Dissecting the regulatory circuitry of a eukaryotic genome Cell 95 717 728
21. P Sudarsanam Y Cao L Wu BC Laurent F Winston 1999 The nucleosome remodeling complex, Snf/Swi, is required for the maintenance of transcription in vivo and is partially redundant with the histone acetylase, Gcn5 EMBO J 18 3101 3106
22. KSJ Foster WJ McCrary JS Ross CF Wright 2006 Members of the hSWI/SNF chromatin remodeling complex associate with and are phosphorylated by protein kinase B/Akt Oncogene 25 4605 4612
23. A Bellacosa D de Feo AK Godwin DW Bell JQ Cheng DA Altomare M Wan L Dubeau G Scambia V Masciullo G Ferrandina P Benedetti Panici S Mancuso G Neri JR Testa 1995 Molecular alterations of the AKT2 oncogene in ovarian and breast carcinomas Int J Cancer 64 280 285
24. J Brognard AS Clark Y Ni PA Dennis 2001 Akt/protein kinase B is constitutively active in non-small cell lung cancer cells and promotes cellular survival and resistance to chemotherapy and radiation Cancer Res 61 3986 3997
25. JQ Cheng AK Godwin A Bellacosa T Taguchi TF Franke T Hamilton PN Tsichlis JR Testa 1992 AKT2, a putative oncogene encoding a member of a subfamily of protein-serine/threonine kinases, is amplified in human ovarian carcinomas Proc Natl Acad Sci USA 89 9267 9271
26. JQ Cheng B Ruggeri WM Klein G Sonoda DA Altomare DK Watson JR Testa 1996 Amplification of AKT2 in human pancreatic cells and inhibition of AKT2 expression and tumorigenicity by antisense RNA Proc Natl Acad Sci USA 93 3636 3641
27. N Gao Z Zhang BH Jiang X Shi 2003 Role of PI3K/AKT/mTOR signaling in the cell cycle progression of human prostate cancer Biochem Biophys Res Commun 310 1124 1132
28. JR Graff BW Konicek AM McNulty ZQ Wang K Houck S Allen JD Paul A Hbaiu RG Goode GE Sandusky RL Vessella BL Neubauer 2000 Increased AKT activity contributes to prostate cancer progression by dramatically accelerating prostate tumor growth and diminishing p27Kip1 expression J Biol Chem 275 24500 24505
29. SR Datta H Dudek X Tao S Masters H Fu Y Gotoh ME Greenberg 1997 Akt phosphorylation of BAD couples survival signals to the cell-intrinsic death machinery Cell 91 231 241
30. TF Franke 1999 A difficult Akt to follow Neural Notes V 2 3 7
31. TF Franke CP Hornik L Segev GA Shostak C Sugimoto 2003 PI3K/Akt and apoptosis: size matters Oncogene 22 8983 8998
32. J Liang J Zubovitz T Petrocelli R Kotchetkov MK Connor K Han JH Lee S Ciarallo C Catzavelos R Beniston E Franssen JM Slingerland 2002 PKB/Akt phosphorylates p27, impairs nuclear import of p27 and opposes p27-mediated G1 arrest Nat Med 10 1153 1160
33. I Shin FM Yakes F Rojo NY Shin AV Bakin J Baselga CL Arteaga 2002 PKB/Akt mediates cell-cycle progression by phophorylation of (Kip1) at threonine 157 and modulation of its cellular localization Nat Med 10 1145 1152
34. BP Zhou Y Liao W Xia B Spohn MH Lee MC Hung 2001 Cytoplasmic localization of p21Cip1/WAF1 by Akt-induced phophorylation in HER-2/new-overexpressing cells Nat Cell Biol 3 245 252
35. R Baserga 2000 The contradictions of the insulin-like growth factor 1 receptor Oncogene 19 5574 5581
36. MG Slomiany LA Black MM Kibbey MA Tingler TA Day SA Rosenzweig 2007 Insulin-like growth factor-1 receptor and ligand targeting in head and neck squamous cell carcinoma Cancer Lett 248 269 279
37. S Ota DC Crabbe TN Tran TJ Triche H Shimada 1993 Malignant rhabdoid tumor. A study with two established cell lines Cancer 71 2862 2872
38. GB Rosson TS Vincent BW Oswald CF Wright 2002 Drug resistance in malignant rhabdoid tumor cell lines Cancer Chemother Pharmacol 49 142 148
39. S Nocentini 2003 Apoptotic response of malignant rhabdoid tumor cells Cancer Cell Int 3 11
40. S Yoshida T Narita S Koshida S Ohta Y Takeuchi 2003 TRAIL/Apo2L ligands induce apoptosis in malignant rhabdoid tumor cell lines Pediatr Res 54 709 717
41. Y Kuwahara H Hosoi S Osone M Kita T Iehara H Kuroda T Sugimoto 2004 Antitumor activity of gefitinib in malignant rhabdoid tumor cells in vitro and in vivo Clin Cancer Res 10 5940 5948
42. A Charboneau J Chai J Jordan W Funkhouser A Judkins J Biegel B Weissman 2006 P-Akt expression distinguishes two types of malignant rhabdoid tumors J Cell Physiol 209 422 427
43. DD Sarbassov DA Guertin SM Ali DM Sabatini 2005 Phosphorylation and regulation of Akt/PKB by the rictor-mTOR complex Science 307 1098 1101
44. RC Hresko M Mueckler 2005 mTOR.RICTOR is the Ser473 kinase for Akt/protein kinase B in 3T3-L1 adipocytes J Biol Chem 280 40406 40416
45. JL Reiter NJ Maihle 2003 Characterization and expression of novel 60-kDa and 110-kDa EGFT isoforms in human placenta Ann NY Acad Sci 995 39 47
46. MA Stellar CH Delgado CJ Bartels CD Woodworth Z Zhiqiang 1996 Overexpression of the Insulin-like Growth Factor-1 Receptor and autocrine stimulation in human cervical cancer cells Cancer Res 56 1761 1765
47. C García-Echeverría MA Pearson A Marti T Meyer J Mestan J Zimmermann J Gao J Brueggen HG Capraro R Cozens DB Evans D Fabbro P Furet DG Porta J Liebetanz G Martiny-Baron S Ruetz F Hofmann 2004 In vivo antitumor activity of NVP-AEW541-A novel, potent, and selective inhibitor of the IGF-IR kinase Cancer Cell 5 231 239
48. J Downward 2003 Targeting RAS signaling pathways in cancer therapy Nat Rev Cancer 3 11 22
49. IB Weinstein 2002 Cancer. Addiction to oncogenes-the Achilles heel of cancer Science 297 63 64
50. DR Mattoon B Lamothe I Lax J Schlessinger 2004 The docking protein Gab1 is the primary mediator of EGF-stimulated activation of the PI-3K/Akt cell survival pathway BMC Biol 2 24
51. D LeRoith H Werner D Beitner-Johnson CT Roberts Jr 1995 Molecular and cellular aspects of the insulin-like growth factor I receptor Endocr Rev 16 143 163
52. K Rajalingam R Schreck UP Rapp A Štefan 2007 Ras oncogenes and their downstream targets Biochim Biophys Acta 1773 1177 1195
53. CWM Roberts MM Leroux MD Fleming SH Orkin 2002 Highly penetrant, rapid tumorigenesis through conditional inversion of the tumor suppressor gene Snf5 Cancer Cell 2 415 425
54. DN Doan TM Veal Z Yan W Wang SN Jones AN Imbalzano 2004 Loss of the INI1 tumor suppressor does not impair the expression of multiple BRG1-dependent genes or the assembly of SWI/SNF enzymes Oncogene 23 3462 3473
55. F Banine C Bartlett R Gunawardena C Muchardt M Yaniv ES Knudsen BE Weissman LS Sherman 2005 SWI/SNF chromatin-remodeling factors induce changes in DNA methylation to promote transcriptional activation Cancer Res 65 3542 3547
56. L Gresh B Bourachot A Reimann B Guigas L Fiette S Garbay C Muchardt L Hue M Pontoglio M Yaniv G Klochendler-Yeivin 2005 The SWI/SNF chromatin-remodeling complex subunit SNF5 is essential for hepatocyte differentiation EMBO J 24 3313 3324
57. B Belandia RL Orford HC Hurst MG Parker 2002 Targeting of SWI/SNF chromatin remodeling complexes to estrogen-responsive genes EMBO J 21 4094 4103
58. J DiRenzo Y Shang M Phelan S Sif M Myers R Kingston M Brown 2000 BRG-1 is recruited to estrogen-responsive promoters and cooperates with factors involved in histone acetylation Mol Cell Biol 20 7541 7549
59. CJ Fryer TK Archer 1998 Chromatin remodeling by the glucocorticoid receptor requires the BRG1 complex Nature 393 88 91
60. KA Link CJ Burd E Williams T Marshall G Rosson E Henry B Weissman KE Knudsen 2005 BAF57 governs androgen receptor action and androgen-dependent proliferation through SWI/SNF Mol Cell Biol 25 2200 2215
61. R Métivier B Penot MR Hübner G Reid H Brand M Kos F Gannon 2003 Estrogen receptor-alpha directs ordered, cyclical, and combinatorial recruitment of cofactors on a natural target promoter Cell 115 751 763